Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
BMC Infectious Diseases|March 7, 2018
Lymphnode tuberculosis in a 4-year-old boy with relapsed ganglioneuroblastoma: a case reportKaroline van de Loo, Stefan Balzer, Colin R MacKenzie, et al.
Genes, Chromosomes & Cancer|April 17, 2014
Chromosome 17/17q gain and unaltered profiles in high resolution array-CGH are prognostically informative in neuroblastomaJessica Theissen, Andre Oberthuer, Anja Hombach, et al.
Breast Care (Basel, Switzerland)|November 1, 2021
Phenotype Discordance between Primary Tumor and Metastasis Impacts Metastasis Site and Outcome: Results of WSG-DETECT-PriMetCornelia Kolberg-Liedtke, Rachel Wuerstlein, Oleg Gluz, et al.
JCO Precision Oncology|February 1, 2022
Telomerase Is a Prognostic Marker of Poor Outcome and a Therapeutic Target in NeuroblastomaAndrea Roderwieser, Frederik Sand, Esther Walter, et al.
British Journal of Cancer|February 22, 2023
Genomic ALK alterations in primary and relapsed neuroblastomaCarolina Rosswog, Jana Fassunke, Angela Ernst, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 6, 2011
A web-based pilot study of inter-pathologist reproducibility using the ISHLT 2004 working formulation for biopsy diagnosis of cardiac allograft rejection: the European experienceAnnalisa Angelini, Claus Boegelund Andersen, Giovanni Bartoloni, et al.
Nature Communications|July 29, 2017
Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemiaGero Knittel, Tim Rehkämper, Darya Korovkina, et al.
Leukemia|November 7, 2019
ATM activity in T cells is critical for immune surveillance of lymphoma in vivoArina Riabinska, Daria Lehrmann, Ron Daniel Jachimowicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markersAndré Oberthuer, Dilafruz Juraeva, Barbara Hero, et al.
Pageof 3